Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20460403rdf:typepubmed:Citationlld:pubmed
pubmed-article:20460403lifeskim:mentionsumls-concept:C0079427lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C0812235lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C1325410lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:20460403lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:20460403pubmed:issue5lld:pubmed
pubmed-article:20460403pubmed:dateCreated2010-5-18lld:pubmed
pubmed-article:20460403pubmed:abstractTextMetastasis is a multistep process that involves the deregulation of oncogenes and tumor suppressors beyond changes required for primary tumor formation. RHOB is known to have tumor suppressor activity, and its knockdown is associated with more aggressive tumors as well as changes in cell shape, migration, and adhesion. This study shows that oncogenic microRNA, miR-21, represses RHOB expression by directly targeting the 3' untranslated region. Loss of miR-21 is associated with an elevation of RHOB in hepatocellular carcinoma cell lines Huh-7 and HepG2 and in the metastatic breast cancer cell line MDA-MB-231. Using in vitro models of distinct stages of metastasis, we showed that loss of miR-21 also causes a reduction in migration, invasion, and cell elongation. The reduction in migration and cell elongation can be mimicked by overexpression of RHOB. Furthermore, changes in miR-21 expression lead to alterations in matrix metalloproteinase-9 activity. Therefore, we conclude that miR-21 promotes multiple components of the metastatic phenotype in vitro by regulating several important tumor suppressors, including RHOB.lld:pubmed
pubmed-article:20460403pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460403pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460403pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460403pubmed:languageenglld:pubmed
pubmed-article:20460403pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460403pubmed:citationSubsetIMlld:pubmed
pubmed-article:20460403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460403pubmed:statusMEDLINElld:pubmed
pubmed-article:20460403pubmed:monthMaylld:pubmed
pubmed-article:20460403pubmed:issn1557-3125lld:pubmed
pubmed-article:20460403pubmed:authorpubmed-author:RoglerCharles...lld:pubmed
pubmed-article:20460403pubmed:authorpubmed-author:ConnollyErin...lld:pubmed
pubmed-article:20460403pubmed:authorpubmed-author:RoglerLeslie...lld:pubmed
pubmed-article:20460403pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:20460403pubmed:copyrightInfo(c)2010 AACR.lld:pubmed
pubmed-article:20460403pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20460403pubmed:volume8lld:pubmed
pubmed-article:20460403pubmed:ownerNLMlld:pubmed
pubmed-article:20460403pubmed:authorsCompleteYlld:pubmed
pubmed-article:20460403pubmed:pagination691-700lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:meshHeadingpubmed-meshheading:20460403...lld:pubmed
pubmed-article:20460403pubmed:year2010lld:pubmed
pubmed-article:20460403pubmed:articleTitleOverexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB.lld:pubmed
pubmed-article:20460403pubmed:affiliationMarion Bessin Liver Research Center, Division of Hepatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.lld:pubmed
pubmed-article:20460403pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20460403pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:388entrezgene:pubmedpubmed-article:20460403lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20460403lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20460403lld:pubmed